Cassava Sciences has given up on simufilam in Alzheimer’s disease. Months after seeing one phase 3 trial fail, the biotech is planning to stop development altogether after chalking up another ...

Cassava Sciences (NASDAQ:SAVA) lost ~19% in the premarket on Tuesday after the company announced plans to discontinue its research program for its lead asset simufilam in Alzheimer’s disease by ...

NEW YORK (Reuters) -The biotechnology company Cassava Sciences failed on Wednesday to end a malicious prosecution lawsuit by doctors and short-sellers who expressed doubts about its experimental ...

Cassava Sciences (NASDAQ:SAVA) said Tuesday it will shut down its Alzheimer's disease program by the end of the second quarter after another Phase 3 trial failure for simufilam, its lead ...

Over time, these beverages can stress the kidneys, damage their delicate filtering units, and affect overall health in ways that might not show up until it’s too late. Here are some of the worst ...

Pan-African technology company Cassava Technologies, in a strategic collaboration with Microsoft, has launched a community engagement initiative focused on South Africa. Through this initiative, the ...

Cassava Technologies plans to build Africa’s first AI factory — a powerful and secure data centre facility powered with Nvidia AI computing technology. The AI Factory is intended to give African ...

Cassava Sciences (SAVA) shared topline results from the Phase 3 REFOCUS-ALZ study of simufilam in mild-to-moderate AD. Topline data indicate that REFOCUS-ALZ did not meet each of the prespecified ...

Cassava Technologies has announced plans to build Africa’s first “AI Factory” — a high-performance, AI-enabled data center powered by NVIDIA’s advanced computing technology. At the ...

Based in the Angolan capital of Luanda, on Africa’s southwest coast, FoodCare is a dried food manufacturer that processes and packages a range of 25 homegrown foods, including cassava ...

Global technology firm, Cassava Technologies, will partner American multinational corporation and technology company, Nvidia Corporation, to build Africa’s first artificial intelligence (AI ...

March 25 (Reuters) - Cassava Sciences (SAVA.O), opens new tab said on Tuesday its Alzheimer's drug simufilam, which has been at the center of regulatory scrutiny, failed in a second late-stage ...